Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Lineage Cell Therapeutics Inc (AMEX: LCTX) was $0.57 for the day, up 0.55% from the previous closing price of $0.57. In other words, the price has increased by $0.55 from its previous closing price. On the day, 1.34 million shares were traded. LCTX stock price reached its highest trading level at $0.588 during the session, while it also had its lowest trading level at $0.56.
Ratios:
Our analysis of LCTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.48 and its Current Ratio is at 2.48. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on August 20, 2024, initiated with a Buy rating and assigned the stock a target price of $4.
On November 02, 2022, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $5.
On June 14, 2022, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $4.B. Riley Securities initiated its Buy rating on June 14, 2022, with a $4 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 26 ’24 when Howe Jill Ann bought 15,000 shares for $0.59 per share. The transaction valued at 8,850 led to the insider holds 25,500 shares of the business.
Samuel George A. III bought 15,000 shares of LCTX for $9,000 on Nov 26 ’24. The General Counsel now owns 22,184 shares after completing the transaction at $0.60 per share. On Nov 22 ’24, another insider, Mulroy Michael H., who serves as the Director of the company, bought 40,000 shares for $0.57 each. As a result, the insider paid 22,640 and bolstered with 298,555 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LCTX now has a Market Capitalization of 126055912 and an Enterprise Value of 130151080. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.45 while its Price-to-Book (P/B) ratio in mrq is 1.63. Its current Enterprise Value per Revenue stands at 21.04 whereas that against EBITDA is -6.083.
Stock Price History:
Over the past 52 weeks, LCTX has reached a high of $1.61, while it has fallen to a 52-week low of $0.50. The 50-Day Moving Average of the stock is -32.00%, while the 200-Day Moving Average is calculated to be -42.84%.
Shares Statistics:
LCTX traded an average of 1.19M shares per day over the past three months and 5330770 shares per day over the past ten days. A total of 188.84M shares are outstanding, with a floating share count of 187.59M. Insiders hold about 0.65% of the company’s shares, while institutions hold 50.59% stake in the company. Shares short for LCTX as of 1730332800 were 15938784 with a Short Ratio of 13.59, compared to 1727654400 on 15221739. Therefore, it implies a Short% of Shares Outstanding of 15938784 and a Short% of Float of 10.89.
